The company has solid fundamentals for a short-term investment strategy.
Share prices are approaching a strong support area in daily data, which offers good timing for investors.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
The stock, which is currently worth 2020 to 0.57 times its sales, is clearly overvalued in comparison with peers.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company sustains low margins.
The group usually releases earnings worse than estimated.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last few months, analysts have been revising downwards their earnings forecast.
For the past year, analysts have significantly revised downwards their profit estimates.
Below the resistance at 110.37 USD, the stock shows a negative configuration when looking looking at the weekly chart.